| __timestamp | BioCryst Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13608000 | 301600000 |
| Thursday, January 1, 2015 | 48257000 | 293461000 |
| Friday, January 1, 2016 | 26353000 | 301853000 |
| Sunday, January 1, 2017 | 25186000 | 331378000 |
| Monday, January 1, 2018 | 20653000 | 343374000 |
| Tuesday, January 1, 2019 | 48835000 | 347337000 |
| Wednesday, January 1, 2020 | 17812000 | 339410000 |
| Friday, January 1, 2021 | 157170000 | 425208000 |
| Saturday, January 1, 2022 | 270827000 | 935061000 |
| Sunday, January 1, 2023 | 331412000 | 1296429000 |
Cracking the code
In the ever-evolving landscape of the pharmaceutical industry, understanding revenue trends is crucial for investors and stakeholders. Over the past decade, Lantheus Holdings, Inc. and BioCryst Pharmaceuticals, Inc. have showcased contrasting revenue trajectories. From 2014 to 2023, Lantheus Holdings experienced a remarkable growth, with revenue surging by over 330%, reaching its peak in 2023. This growth reflects the company's strategic advancements and market adaptability.
Conversely, BioCryst Pharmaceuticals, while showing a steady increase, saw a more modest growth of approximately 230% over the same period. The year 2023 marked a significant milestone for BioCryst, with revenues reaching their highest point, indicating potential breakthroughs in their product offerings. These trends highlight the dynamic nature of the pharmaceutical sector, where innovation and strategic positioning play pivotal roles in financial success.
Novartis AG and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? Biogen Inc. or Lantheus Holdings, Inc.
Breaking Down Revenue Trends: Bio-Techne Corporation vs BioCryst Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Ascendis Pharma A/S and Lantheus Holdings, Inc. Performance Compared
Lantheus Holdings, Inc. and Alkermes plc: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Lantheus Holdings, Inc. vs Arrowhead Pharmaceuticals, Inc.
Revenue Insights: Lantheus Holdings, Inc. and Geron Corporation Performance Compared
Who Generates More Revenue? Lantheus Holdings, Inc. or Amphastar Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Lantheus Holdings, Inc. and BioCryst Pharmaceuticals, Inc.
Revenue Showdown: Ligand Pharmaceuticals Incorporated vs BioCryst Pharmaceuticals, Inc.
Revenue Insights: BioCryst Pharmaceuticals, Inc. and MiMedx Group, Inc. Performance Compared